Geode Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-670,206
| Closed | -$13M | – | 4161 |
|
|
2018
Q1 | $13M | Buy |
670,206
+12,175
| +2% | +$239K | ﹤0.01% | 1572 |
|
|
2017
Q4 | $11M | Sell |
658,031
-7,690
| -1% | -$141K | ﹤0.01% | 1672 |
|
|
2017
Q3 | $13.5M | Buy |
665,721
+16,577
| +3% | +$317K | 0.01% | 1514 |
|
|
2017
Q2 | $10.5M | Sell |
649,144
-33,416
| -5% | -$494K | ﹤0.01% | 1631 |
|
|
2017
Q1 | $8.63M | Sell |
682,560
-5,241
| -0.8% | -$63.3K | ﹤0.01% | 1720 |
|
|
2016
Q4 | $9.11M | Buy |
687,801
+95,391
| +16% | +$1.63M | ﹤0.01% | 1642 |
|
|
2016
Q3 | $14M | Buy |
592,410
+9,587
| +2% | +$258K | 0.01% | 1245 |
|
|
2016
Q2 | $16.8M | Buy |
582,823
+82,673
| +17% | +$2.69M | 0.01% | 1057 |
|
|
2016
Q1 | $16K | Buy |
500,150
+31,387
| +7% | +$1.1M | 0.01% | 1063 |
|
|
2015
Q4 | $20M | Buy |
468,763
+20,285
| +5% | +$810K | 0.01% | 889 |
|
|
2015
Q3 | $15.8M | Sell |
448,478
-2,193
| -0.5% | -$98.8K | 0.01% | 1027 |
|
|
2015
Q2 | $20.7M | Buy |
450,671
+3,467
| +0.8% | +$165K | 0.01% | 916 |
|
|
2015
Q1 | $21M | Buy |
447,204
+29,397
| +7% | +$1.17M | 0.01% | 898 |
|
|
2014
Q4 | $13.2M | Buy |
417,807
+26,882
| +7% | +$787K | 0.01% | 1114 |
|
|
2014
Q3 | $9.27M | Buy |
390,925
+1,445
| +0.4% | +$37K | 0.01% | 1324 |
|
|
2014
Q2 | $11.7M | Buy |
389,480
+4,982
| +1% | +$134K | 0.01% | 1187 |
|
|
2014
Q1 | $10.2M | Buy |
384,498
+39,221
| +11% | +$980K | 0.01% | 1240 |
|
|
2013
Q4 | $8.68M | Buy |
345,277
+36,670
| +12% | +$818K | 0.01% | 1298 |
|
|
2013
Q3 | $6.33M | Buy |
308,607
+40,205
| +15% | +$830K | 0.01% | 1392 |
|
|
2013
Q2 | $5.36M | Buy |
+268,402
| New | +$4.76M | ﹤0.01% | 1369 |
|
Geode Capital Management's IPXL Position: Q2 2018 in Review
Geode Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 670,206 shares — an estimated $13M sold.
Geode Capital Management first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $21M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Geode Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Geode Capital Management sold 670,206 Impax Laboratories, Inc. shares in Q2 2018, an estimated $13M.
- Geode Capital Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Geode Capital Management's Impax Laboratories, Inc. position peaked at $21M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Geode Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.